The course of hepatitis C viraemia in transfusion recipients prior to availability of antiviral therapy | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

The course of hepatitis C viraemia in transfusion recipients prior to availability of antiviral therapy

Mosley JW, Operskalski EA, Tobler LH, et al. The course of hepatitis C viraemia in transfusion recipients prior to availability of antiviral therapy. J Viral Hepat. 2008;15(2):120-128.

Publication Type:

Journal Article

Authors:

Mosley, J.W.; Operskalski, E.A.; Tobler, L.H.; et, al

Source:

J Viral Hepat, Volume 15, Issue 2, p.120-128 (2008)

Keywords:

adverse effects, Alanine, Alanine Transaminase, Antiviral Agents, blood, Blood Donors, Blood Transfusion, California, drug effects, Genotype, HCV, Hepacivirus, hepatitis, Hepatitis C, Humans, immunology, Infection, Los Angeles, Medicine, microbiology, Patients, physiopathology, Prospective Studies, PROVIDE, Research, Research Support, Rna, Rna,Viral, Serum, therapeutic use, therapy, transmission, Veterans, Viral Load, Viremia, Viruses, Women

Cited On:

Management of Acute HCV Infection

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/18184195

Export Citation:

RIS Format

Top